TY  - JOUR
AU  - Sánchez-Alcoholado, Lidia
AU  - Laborda-Illanes, Aurora
AU  - Otero, Ana
AU  - Ordóñez, Rafael
AU  - González-González, Alicia
AU  - Plaza-Andrades, Isaac
AU  - Ramos-Molina, Bruno
AU  - Gómez-Millán, Jaime
AU  - Queipo-Ortuño, María Isabel
PY  - 2021
DO  - 10.3390/ijms22179549
UR  - http://hdl.handle.net/10668/18511
T2  - International journal of molecular sciences
AB  - Emerging evidence has suggested that dysbiosis of the gut microbiota may influence the drug efficacy of colorectal cancer (CRC) patients during cancer treatment by modulating drug metabolism and the host immune response. Moreover, gut microbiota can...
LA  - en
KW  - SCFAs
KW  - colorectal cancer
KW  - gut microbiota
KW  - gut permeability
KW  - radiochemotherapy
KW  - treatment outcome
KW  - Aged
KW  - Case-Control Studies
KW  - Colorectal Neoplasms
KW  - Fatty Acids, Volatile
KW  - Feces
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Intestinal Mucosa
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Permeability
KW  - Polyamines
KW  - Treatment Outcome
TI  - Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
TY  - research article
VL  - 22
ER  -